Improving the visual outcome in Leber's hereditary optic neuropathy: Framework for the future

Samuel Asanad; Starleen Frousiakis; Michelle Y Wang; Michele Fantini; William Sultan; Terry Wood; Francis U Nwako; Rustum Karanjia; Alfredo A Sadun

doi:10.1016/j.joco.2019.05.004

Improving the visual outcome in Leber's hereditary optic neuropathy: Framework for the future

J Curr Ophthalmol. 2019 Jun 6;31(3):251-253. doi: 10.1016/j.joco.2019.05.004. eCollection 2019 Sep.

Authors

Samuel Asanad^{1

2

1

3

1

4

1

5

1

1

1

1

2

6

7

1

2}, Starleen Frousiakis^{1

3

1

4

1

5

1

1

1

1

2

6

7

1

2}, Michelle Y Wang^{1

4

1

5

1

1

1

1

2

6

7

1

2}, Michele Fantini^{1

5

1

1

1

1

2

6

7

1

2}, William Sultan^{1

1

1

1

2

6

7

1

2}, Terry Wood^{1

1

1

2

6

7

1

2}, Francis U Nwako^{1

1

2

6

7

1

2}, Rustum Karanjia^{1

2

6

7

1

2}, Alfredo A Sadun^{1

2}

Affiliations

¹ Doheny Eye Institute, Los Angeles, CA, USA.
² Department of Ophthalmology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
³ Department of Internal Medicine, Huntington Memorial Hospital, Pasadena, CA, USA.
⁴ Department of Ophthalmology, Southern California Permanente Medical Group, Los Angeles, CA, USA.
⁵ University of Udine, Department of Ophthalmology, Udine, Italy.
⁶ Department of Ophthalmology, University of Ottawa, Ottawa, Ontario, Canada.
⁷ Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

No abstract available

Keywords: Advances; Biomarkers; Gene therapy; Leber's hereditary optic neuropathy; Natural history; Visual recovery.

Publication types

Editorial